Compare Badger Meter Inc (BMI) vs BioNano Genomics Inc (BNGO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Badger Meter Inc vs BioNano Genomics Inc — how do they compare? Badger Meter Inc trades at $134.49 (market cap $3.93B), while BioNano Genomics Inc trades at $1.18 (market cap $13.66M). The key difference: Badger Meter Inc is far larger — about 287.7× BioNano Genomics Inc's market cap, and Badger Meter Inc pays a 1.18% dividend while BioNano Genomics Inc pays none. Which is the better fit depends on your goals.
| BMI | BNGO | |
|---|---|---|
Market Cap | $3.93B | $13.66M |
Sector | Technology | Health |
52-Week High | $193.09 | $4.92 |
52-Week Low | $113.41 | $1.06 |
Enterprise Value | $3.84B | $16.26M |
Dividend Yield | 1.18% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Badger Meter (BMI) trades at $133.63, down 2.06% amid bearish technical signals and mixed earnings performance. The stock shows strong profitability with 14.27% net margin and 18.48% ROE, but faces headwinds from recent securities class action lawsuits and declining revenue projections for 2026. Technical indicators suggest bearish momentum with resistance at $137-$139 levels.
While BMI maintains solid fundamentals and analyst consensus targets $155.20 (16% upside), near-term risks include legal uncertainties and earnings volatility. The company's water technology focus provides defensive characteristics, but investors should weigh class action litigation risks against the stock's valuation premium (P/E 31.78).
BNGO trades at $1.195, up 3.02% today, with a bullish technical signal from moving averages but a neutral oscillator stance. The company shows improving financial trends, with net losses narrowing to -$26.40M in 2025 from -$232M in 2023, and recent earnings beats. Revenue stabilized around $29M, while cash flow trends indicate reduced operational cash burn. Analyst sentiment is positive, with 57% buy ratings.
The outlook for BNGO hinges on sustaining revenue growth and achieving profitability, supported by strategic hires and debt retirement. Key risks include persistent negative margins and high cash burn. With a low P/S of 0.31, the stock offers value if execution improves, but investors face volatility from operational challenges and competitive pressures.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Badger Meter Inc
Badger Meter provides industry-leading water management solutions. Its smart measurement hardware and software analytics help water utilities and industrial customers optimize operations and conserve natural resources.
Read more on BMI →About BioNano Genomics Inc
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes.
Read more on BNGO →
